Does Wegovy cause hair loss, and what can you do about it?

Step 1: Understand what is actually happening to the hair cycle

Hair grows in cycles. At any point, most follicles are in the anagen (growth) phase, while a smaller proportion rest in telogen before shedding. When the body experiences a significant physiological stress (rapid weight loss, surgery, illness, a dramatic calorie cut) a large cohort of follicles can shift into telogen simultaneously. Two to four months later, those follicles shed. The result is diffuse thinning rather than patchy loss, and it can look alarming even when the total volume lost is within a range the follicle will recover from.

Semaglutide, the active ingredient in Wegovy, does not appear to directly cause this; the NHS medicines page for semaglutide lists hair loss among reported side effects but frames it in this exact context: the body's response to rapid weight change. The mechanism is the stress of the metabolic shift, not the drug acting on the follicle. That distinction matters for how you respond to it.

Telogen effluvium from weight loss is also documented in people who lose weight by other means (bariatric surgery, very-low-calorie diets) at similar rates. What is specific to GLP-1 treatment is the speed at which appetite and intake can fall, which is why it appears in Wegovy trials more visibly than in slower weight-loss programmes.

Step 2: Identify the factors that make it worse (and the ones you can control)

The biggest modifiable contributor is protein intake. When appetite drops sharply on Wegovy, the foods that tend to disappear first are calorie-dense ones, which often also carry the protein. If total protein falls below what the body needs to maintain lean tissue, hair becomes an early casualty. Muscle loss and hair loss often share this upstream cause: not enough amino acids to maintain everything.

Micronutrient gaps can compound the problem. Iron deficiency, in particular, is strongly associated with telogen effluvium in women. Zinc, biotin, and ferritin levels are worth checking with your GP if shedding is significant. A simple blood panel can tell you whether a deficiency is driving the picture rather than weight loss alone.

Calorie restriction speed also plays a role. People who lose weight quickly (which Wegovy can facilitate) tend to experience more pronounced telogen effluvium than those whose weight declines more gradually. This is not a reason to avoid treatment; it is a reason to work with your prescriber on titration pace and to prioritise nutritional adequacy throughout.

Stress, sleep, and thyroid function interact with the same cycle. A prescriber who knows your full picture (not just your weight trajectory) is best placed to untangle which factors are at play. Our clinical team at nume reviews each patient's situation personally before and during treatment.

Step 3: Know what to do, and when to seek advice

For most people, the practical response is: keep going, focus on protein, and give it time. Aim for at least 1.2–1.6g of protein per kilogram of body weight daily, more if you are doing resistance training alongside treatment, which has the added benefit of preserving muscle. Protecting lean mass during weight loss is worth taking seriously regardless of hair concerns.

Topical treatments such as minoxidil have evidence for androgenetic alopecia but limited specific evidence for telogen effluvium; they are not routinely recommended for this presentation. Biotin supplements are widely sold but the evidence base for hair loss in people without a diagnosed deficiency is thin. A balanced diet that actually delivers the micronutrients matters more than any supplement stack.

You should speak to your prescriber if: shedding is severe enough to leave visible scalp patches rather than diffuse thinning; it continues beyond nine months with no sign of slowing; you develop other symptoms such as fatigue, intolerance to cold, or skin changes that might point to thyroid dysfunction; or the psychological impact is significant. Hair loss can feel distressing even when it is medically benign, and that is a legitimate clinical concern in its own right.

It is also worth checking whether any other medicines you take interact with the hair cycle, oral contraceptives, for instance, can affect shedding when started or stopped. If you are considering Wegovy for the first time and want to think through the full side-effect picture, the semaglutide overview on our site covers the broader evidence, and you can always review the NHS semaglutide medicines page for the official patient-level summary. The MHRA Yellow Card scheme is there if you want to report a side effect you are experiencing.

Step 4: Put hair loss in the context of the overall treatment picture

Telogen effluvium is real, it is worth knowing about in advance, and it is temporary for the vast majority of people. Set against the cardiovascular, metabolic, and joint-health benefits that meaningful weight reduction brings (benefits documented in the large-scale trials behind Wegovy's weight-loss evidence) transient shedding is a side effect that most patients and clinicians consider manageable rather than prohibitive.

That said, no one should start a prescription medicine without understanding what to expect. Some people do find the shedding distressing enough to want support, and that is a valid thing to raise. If you are weighing up whether Wegovy is right for you (including how its side-effect profile compares to alternatives, and what the cost of private treatment looks like) a free consultation with a prescriber is the right starting point. Every person's situation is different, and a clinician who has seen your full history is better placed to advise than any webpage.

Speak to our prescribers through our treatment page, it is free, reviewed the same day by a real clinician, and there is no obligation to proceed.